HK1139135A1 - Process for the preparation of pleuromutilins - Google Patents
Process for the preparation of pleuromutilinsInfo
- Publication number
- HK1139135A1 HK1139135A1 HK10104886.7A HK10104886A HK1139135A1 HK 1139135 A1 HK1139135 A1 HK 1139135A1 HK 10104886 A HK10104886 A HK 10104886A HK 1139135 A1 HK1139135 A1 HK 1139135A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparation
- sulfanyl
- butyryl
- acetyl
- amino
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 2
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 2
- OBUUFWIMEGVAQS-UHFFFAOYSA-N Pleuromutenol Natural products CC1C(O)C(C)(C=C)CC(O)C2(C)C(C)CCC31C2C(=O)CC3 OBUUFWIMEGVAQS-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 238000011031 large-scale manufacturing process Methods 0.000 abstract 1
- 125000003386 piperidinyl group Chemical group 0.000 abstract 1
- STZYTFJPGGDRJD-NHUWBDDWSA-N retapamulin Chemical compound C([C@H]([C@@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CS[C@@H]3C[C@H]4CC[C@H](N4C)C3)C)C[C@]32[C@H]1C(=O)CC3 STZYTFJPGGDRJD-NHUWBDDWSA-N 0.000 abstract 1
- 229960002771 retapamulin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06121852A EP1908750A1 (en) | 2006-10-05 | 2006-10-05 | Process for the preparation of pleuromutilins |
| PCT/AT2007/000468 WO2008040043A1 (en) | 2006-10-05 | 2007-10-03 | Process for the preparation of pleuromutilins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1139135A1 true HK1139135A1 (en) | 2010-09-10 |
Family
ID=37781773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK10104886.7A HK1139135A1 (en) | 2006-10-05 | 2010-05-18 | Process for the preparation of pleuromutilins |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US8334389B2 (hr) |
| EP (3) | EP1908750A1 (hr) |
| JP (1) | JP5557530B2 (hr) |
| KR (1) | KR101577675B1 (hr) |
| CN (1) | CN101595090B (hr) |
| AT (1) | ATE523490T1 (hr) |
| AU (1) | AU2007304867B2 (hr) |
| BR (1) | BRPI0719205B8 (hr) |
| CA (1) | CA2665347C (hr) |
| ES (1) | ES2373341T3 (hr) |
| HK (1) | HK1139135A1 (hr) |
| HR (1) | HRP20090192B1 (hr) |
| IL (1) | IL197970A (hr) |
| MX (1) | MX2009003681A (hr) |
| MY (1) | MY146357A (hr) |
| NO (1) | NO341868B1 (hr) |
| NZ (1) | NZ576034A (hr) |
| RU (1) | RU2512591C2 (hr) |
| TW (1) | TWI432416B (hr) |
| UA (1) | UA96775C2 (hr) |
| WO (1) | WO2008040043A1 (hr) |
| ZA (1) | ZA200902159B (hr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011115069A1 (ja) * | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 結晶の網羅的探索 |
| EP2399904A1 (en) * | 2010-05-26 | 2011-12-28 | Nabriva Therapeutics AG | Process for the preparation of pleuromutilins |
| CN104803911B (zh) * | 2014-01-23 | 2018-01-05 | 中国科学院上海药物研究所 | 一类截短侧耳素化合物、其药物组合物、合成方法与用途 |
| TWI762573B (zh) | 2017-02-10 | 2022-05-01 | 奧地利商納畢瓦治療有限責任公司 | 截短側耳素之純化 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3405632A1 (de) * | 1984-02-17 | 1985-08-22 | Sandoz-Patent-GmbH, 7850 Lörrach | Neue pleuromutilinderivate, verfahren zu ihrer herstellung und ihre verwendung |
| HU208115B (en) * | 1989-10-03 | 1993-08-30 | Biochemie Gmbh | New process for producting pleuromutilin derivatives |
| GB9918037D0 (en) * | 1999-07-30 | 1999-09-29 | Biochemie Gmbh | Organic compounds |
| PE20020676A1 (es) * | 2000-09-13 | 2002-08-27 | Biochemie Gmbh | Compuestos de mutilina como antibacterianos |
| SI1534678T1 (sl) * | 2002-07-24 | 2008-06-30 | Nabriva Therapeutics Ag | Plevromutilinski derivati kot antimikrobna sredstva |
-
2006
- 2006-10-05 EP EP06121852A patent/EP1908750A1/en not_active Withdrawn
-
2007
- 2007-10-03 EP EP10009550A patent/EP2272829A3/en not_active Withdrawn
- 2007-10-03 ZA ZA200902159A patent/ZA200902159B/xx unknown
- 2007-10-03 BR BRPI0719205A patent/BRPI0719205B8/pt active IP Right Grant
- 2007-10-03 TW TW096137112A patent/TWI432416B/zh not_active IP Right Cessation
- 2007-10-03 AU AU2007304867A patent/AU2007304867B2/en not_active Ceased
- 2007-10-03 AT AT07815135T patent/ATE523490T1/de not_active IP Right Cessation
- 2007-10-03 ES ES07815135T patent/ES2373341T3/es active Active
- 2007-10-03 MX MX2009003681A patent/MX2009003681A/es active IP Right Grant
- 2007-10-03 CN CN200780045162.5A patent/CN101595090B/zh active Active
- 2007-10-03 WO PCT/AT2007/000468 patent/WO2008040043A1/en active Application Filing
- 2007-10-03 NZ NZ576034A patent/NZ576034A/en unknown
- 2007-10-03 UA UAA200904312A patent/UA96775C2/ru unknown
- 2007-10-03 MY MYPI20091363A patent/MY146357A/en unknown
- 2007-10-03 JP JP2009530732A patent/JP5557530B2/ja not_active Expired - Fee Related
- 2007-10-03 US US12/444,330 patent/US8334389B2/en active Active
- 2007-10-03 KR KR1020097008971A patent/KR101577675B1/ko active IP Right Grant
- 2007-10-03 CA CA2665347A patent/CA2665347C/en active Active
- 2007-10-03 EP EP07815135A patent/EP2069301B1/en active Active
- 2007-10-03 RU RU2009116945/04A patent/RU2512591C2/ru active
-
2009
- 2009-03-26 NO NO20091261A patent/NO341868B1/no unknown
- 2009-04-01 HR HRP20090192AA patent/HRP20090192B1/hr not_active IP Right Cessation
- 2009-04-05 IL IL197970A patent/IL197970A/en active IP Right Grant
-
2010
- 2010-05-18 HK HK10104886.7A patent/HK1139135A1/xx not_active IP Right Cessation
-
2012
- 2012-10-26 US US13/662,063 patent/US8624033B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200640949A (en) | Hyper-branched polymer and process for producing the same | |
| TW200745069A (en) | Novel 1,4-benzothiazepine 1,1-dioxide derivative with improved properties, process for its preparation, medicaments comprising this compound and its use | |
| WO2009102155A3 (en) | Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds | |
| TW200745070A (en) | Novel 1,4-benzothiazepine 1,1-dioxide derivative with improved properties, process for its preparation, medicaments comprising this compound and their use | |
| UA88812C2 (ru) | Способ получения этилена и способ окисления этана | |
| HK1113363A1 (en) | Inhibitors of e1 activating enzymes e1 | |
| GB0719180D0 (en) | New process | |
| RS51892B (en) | DROSPIRENON PREPARATION PROCESS | |
| HK1139135A1 (en) | Process for the preparation of pleuromutilins | |
| SG170794A1 (en) | Process for preparation of hiv protease inhibitors | |
| TW200801259A (en) | Production process for high purity polycrystal silicon and production apparatus for the same | |
| JO2781B1 (en) | A new process for the synthesis of ivabradine and its addition salts with pharmaceutically acceptable acid. | |
| IL200811A0 (en) | Methods for the preparation of n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives | |
| HK1138829A1 (en) | (-)- stereoisomer of 2,6-di-sec-butylphenol and analogs thereof | |
| WO2008090819A1 (ja) | 二環性プロリン化合物の製造方法 | |
| JO2782B1 (en) | A new process for the synthesis of ivabradine and its addition salts with pharmaceutically acceptable acid. | |
| MX2010001512A (es) | Nuevo procedimiento de preparacion. | |
| UA74114U (ru) | Производные 5-гидрокси-4-аминометил-1-циклогексил (или циклогептил)-3-алкоксикарбонилиндолов, их фармацевтически приемлемые соли, которые имеют противовирусную активность | |
| SG195161A1 (en) | Method for producing proline compound | |
| NZ589496A (en) | Processes and compounds for the preparation of normorphinans | |
| TW200624422A (en) | Process for production of 2-chloro-4-nitroimidazole | |
| WO2008111563A1 (ja) | 鉄サラン錯体触媒を用いた光学活性スルホキシド化合物の製造法 | |
| EP2189450A4 (en) | PROCESS FOR THE PREPARATION OF A CHINAZOLINE DERIVATIVE | |
| MY161959A (en) | Continuous production of high purity carbon dioxide | |
| TW200724527A (en) | Process for the production of hydroxyalkylmaleimides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20231003 |